Bioniche Life Sciences Inc. Announces the Appointment of a New Chief Executive Officer


BELLEVILLE, ON, Nov. 4, 2013 /CNW/ – (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has hired Dr. Michael Berendt as its new CEO effective immediately. Dr. Berendt replaces Mr. Graeme McRae in this role. Earlier this year, Mr. McRae announced his intention to retire and assume the role of Founder and Chairman Emeritus of the Company’s Board of Directors.
“The Board of Directors, management team, employees and shareholders acknowledge Graeme’s significant contribution, while welcoming Dr. Berendt to the Bioniche team,” said Mr. James Rae, Chairman of the Bioniche Life Sciences Inc. Board of Directors. “Dr. Berendt has an established background in the life sciences sector, most recently serving as President & CEO of Aegera Therapeutics Inc. in Montréal, Québec.”
Dr. Berendt held positions of increasing responsibility in the U.S. research departments of Pfizer, Inc. and Bayer Corporation before becoming Managing Director, Life Sciences Sector of AEA Investors, then Managing Director of Research Corporation Technologies. In 2006, he became the President & CEO of Aegera, which was sold to Pharmascience in 2011.
Dr. Berendt graduated with a B.S. from Ohio Dominican University, a M.S. from Miami University, and a Ph.D. in Medical Microbiology and Immunology from Drexel University. Dr. Berendt is a Director on the Boards of Waters Corporation and NeoMed Institute. He serves as Chairman of Anchor Therapeutics and serves as Chairman of Alethia Biothérapeutiques.
Dr. Berendt will be attending the Company’s Annual and Special Meeting of Shareholders, being held on Tuesday, November 5, 2013 at 4:00 p.m. Eastern in Belleville, Ontario.
About Bioniche Life Sciences Inc.
Bioniche Life Sciences Inc. is a research-based, technology-driven Canadian biopharmaceutical company focused on the discovery, development,…Read more

Pharmalive – The Pulse of the Pharmaceutical Industry

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS